{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:01:20Z","timestamp":1791662480511,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijrobp.2024.10.023","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T06:42:15Z","timestamp":1729665735000},"page":"1042-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-9338","authenticated-orcid":false,"given":"Abigail","family":"Pepin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina","family":"Chesnokova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Pishko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gysler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kassick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil K.","family":"Taunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.10.023_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","volume":"157","author":"Sinno","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0002","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.6004\/jnccn.2018.7023","article-title":"Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer","volume":"16","author":"Gargus","year":"2018","journal-title":"J Natl Compr Can Netw"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0003","first-page":"134","article-title":"Different approaches to hormone replacement therapy in women with premature ovarian insufficiency","volume":"3","author":"Kiesel","year":"2021","journal-title":"GREM - Gynecol Reprod Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygyno.2011.03.012","article-title":"Hormone replacement therapy in gynecologic cancer survivors: why not?","volume":"122","author":"Ibeanu","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijrobp.2024.10.023_bib0005","first-page":"CD004143","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0006","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0008","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/gme.0b013e31824bb039","article-title":"A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative","volume":"19","author":"Steinkellner","year":"2012","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0009","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results","volume":"26","author":"Crawford","year":"2018","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2017.09.009","article-title":"Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?","volume":"147","author":"Rauh","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0011","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ijrobp.2008.12.016","article-title":"The impact of radiotherapy on fertility, pregnancy, and neonatal outcomes of female cancer patients","volume":"73","author":"Wo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0012","series-title":"Speroff's Clinical Gynecologic Endocrinology and Infertility","author":"Taylor","year":"2019"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0013","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","article-title":"The radiosensitivity of the human oocyte","volume":"18","author":"Wallace","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0014","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1016\/j.ijrobp.2022.07.1702","article-title":"Acute ovarian failure and premature ovarian insufficiency in childhood cancer survivors who received radiotherapy: A PENTEC Report","volume":"114","author":"Hill-Kayser","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0015","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jc.2003-030352","article-title":"Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer","volume":"88","author":"Larsen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0016","first-page":"573","article-title":"Practical prediction model for ovarian insufficiency after radiation","volume":"44","author":"Gil","year":"2022","journal-title":"RBGO Gynecol Obstet"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0017","doi-asserted-by":"crossref","first-page":"e0277052","DOI":"10.1371\/journal.pone.0277052","article-title":"A predictive model of the effect of therapeutic radiation on the human ovary","volume":"17","author":"Kelsey","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijrobp.2020.07.2320","article-title":"Proton radiotherapy to preserve fertility and endocrine function: a translational investigation","volume":"109","author":"Gross","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0019","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13014-019-1312-2","article-title":"Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint","volume":"14","author":"Yin","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0020","doi-asserted-by":"crossref","first-page":"100804","DOI":"10.1016\/j.adro.2021.100804","article-title":"Ovarian transposition before pelvic radiation therapy: spatial distribution and dose volume analysis","volume":"7","author":"Gay","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0021","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12905-022-01887-8","article-title":"Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis","volume":"22","author":"Laios","year":"2022","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0022","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0023","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2008-1878","article-title":"Bone mineral density in estrogen-deficient young women","volume":"94","author":"Popat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0024","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/gme.0b013e31804c793d","article-title":"Effect of early menopause on bone mineral density and fractures","volume":"14","author":"Gallagher","year":"2007","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-5122(94)90061-2","article-title":"Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures","volume":"19","author":"Vega","year":"1994","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0026","unstructured":"Hormone Therapy in Primary Ovarian Insufficiency. American College of Obstetricians and Gynecologists. Available at: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/05\/hormone-therapy-in-primary-ovarian-insufficiency. Accessed November 12, 2023."},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0027","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1359\/JBMR.040215","article-title":"Risk factors for incident vertebral fractures in men and women: the Rotterdam Study","volume":"19","author":"van der Klift","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0028","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1210\/jc.2013-4145","article-title":"Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement","volume":"99","author":"Popat","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0029","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1210\/jc.2015-4063","article-title":"Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density","volume":"101","author":"Cartwright","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0031","first-page":"e134","article-title":"Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency","volume":"129","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0032","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0033","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1210\/jc.2004-0015","article-title":"Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy","volume":"89","author":"Kalantaridou","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0034","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2016-1141","article-title":"Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age","volume":"101","author":"Daan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ijrobp.2024.10.023_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/HYPERTENSIONAHA.108.126516","article-title":"Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure","volume":"53","author":"Langrish","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0036","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2265.2007.02772.x","article-title":"A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism","volume":"66","author":"Ostberg","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0037","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0043-1770088","article-title":"Cardiovascular risk factors in premature ovarian insufficiency using hormonal therapy","volume":"45","author":"Rezende","year":"2023","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0038","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12020-016-1046-y","article-title":"Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis","volume":"55","author":"Cintron","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0039","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0895-4356(98)00170-X","article-title":"Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study","volume":"52","author":"Jacobsen","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(96)90075-6","article-title":"Age at menopause as a risk factor for cardiovascular mortality","volume":"347","author":"van der Schouw","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.maturitas.2021.04.003","article-title":"Metabolic profile of women with premature ovarian insufficiency compared with that of age-matched healthy controls","volume":"148","author":"Huang","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0042","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/jcm7100374","article-title":"Metabolic profile of patients with premature ovarian insufficiency","volume":"7","author":"Podfigurna","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0043","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.maturitas.2014.07.008","article-title":"Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls","volume":"79","author":"Ates","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0044","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/GME.0000000000002120","article-title":"Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls","volume":"30","author":"Li","year":"2023","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0045","first-page":"127","article-title":"Consequences of premature ovarian insufficiency on women's sexual health","volume":"17","author":"Maciejewska-Jeske","year":"2018","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/gme.0b013e3180f6108c","article-title":"Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure","volume":"15","author":"van der Stege","year":"2008","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0047","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/13697137.2019.1575356","article-title":"Sexuality in premature ovarian insufficiency","volume":"22","author":"Nappi","year":"2019","journal-title":"Climacteric"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0048","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2021.08.036","article-title":"Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes after definitive chemoradiotherapy in patients with locally advanced cervical cancer: results from the EMBRACE-I Study","volume":"112","author":"Kirchheiner","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0049","doi-asserted-by":"crossref","first-page":"107994","DOI":"10.1016\/j.maturitas.2024.107994","article-title":"Sexual function in women with premature ovarian insufficiency (POI): Systematic review and meta-analysis","volume":"184","author":"van Zwol-Janssens","year":"2024","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0050","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.fertnstert.2007.08.040","article-title":"Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency","volume":"90","author":"Kalantaridou","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11136-019-02326-2","article-title":"Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis","volume":"29","author":"Li","year":"2020","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0052","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0053","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000314681","article-title":"Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study","volume":"30","author":"Phung","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0054","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1212\/WNL.0000000000000033","article-title":"Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women","volume":"82","author":"Bove","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0055","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women's health initiative memory study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0056","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0057","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/kwi324","article-title":"Age at natural menopause and cause-specific mortality","volume":"162","author":"Mondul","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0058","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/aje\/kwg066","article-title":"Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women","volume":"157","author":"Jacobsen","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0059","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5122(02)00183-4","article-title":"Lifetime estrogen exposure versus age at menopause as mortality predictor","volume":"43","author":"Jansen","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0060","doi-asserted-by":"crossref","first-page":"hox007","DOI":"10.1093\/hropen\/hox007","article-title":"HRT for women with premature ovarian insufficiency: a comprehensive review","volume":"2017","author":"Webber","year":"2017","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0061","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2010.04.011","article-title":"EMAS position statement: Managing women with premature ovarian failure","volume":"67","author":"Vujovic","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0062","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS Recommendations on women's midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0063","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0064","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697137.2019.1632284","article-title":"Tailored hormonal approach in women with premature ovarian insufficiency","volume":"23","author":"Fruzzetti","year":"2020","journal-title":"Climacteric"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/13697137.2020.1804547","article-title":"Premature ovarian insufficiency: an International Menopause Society White Paper","volume":"23","author":"Panay","year":"2020","journal-title":"Climacteric J Int Menopause Soc"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0066","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/2053369117699358","article-title":"British Menopause Society and Women's Health Concern. The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency","volume":"23","author":"Hamoda","year":"2017","journal-title":"Post Reprod Health"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0067","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.12688\/f1000research.11948.1","article-title":"Premature ovarian insufficiency - an update on recent advances in understanding and management","volume":"6","author":"Torrealday","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0068","first-page":"135","article-title":"Premature ovarian insufficiency - hormone replacement therapy and management of long-term consequences","volume":"17","author":"Machura","year":"2018","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0069","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.maturitas.2020.11.004","article-title":"Premature ovarian insufficiency: A toolkit for the primary care physician","volume":"147","author":"Lambrinoudaki","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0070","doi-asserted-by":"crossref","first-page":"100730","DOI":"10.1016\/j.blre.2020.100730","article-title":"Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations","volume":"45","author":"Cattoni","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0071","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0072","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in Stage I or II endometrial cancer: A Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0073","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis","volume":"50","author":"Shim","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0074","doi-asserted-by":"crossref","unstructured":"Hormone replacement therapy for women previously treated for endometrial cancer - Edey, KA - 2018 | Cochrane Library. Available at: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008830.pub3\/abstract. Accessed August 22, 2023.","DOI":"10.1002\/14651858.CD008830.pub3"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0090-8258(86)90134-4","article-title":"The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix","volume":"23","author":"Martin","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0076","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0090-8258(87)90270-8","article-title":"Hormonal replacement therapy in patients after cervical cancer treatment","volume":"26","author":"Ploch","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0077","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ijgc-2022-003861","article-title":"Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause","volume":"33","author":"Suzuki","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0078","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0079","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0080","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/j.clcc.2018.01.003","article-title":"Hormone replacement therapy and colorectal cancer incidence and mortality in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"17","author":"Symer","year":"2018","journal-title":"Clin Colorectal Cancer"},{"issue":"7","key":"10.1016\/j.ijrobp.2024.10.023_bib0081","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","article-title":"Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause","volume":"106","author":"Sullivan","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0082","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0083","unstructured":"Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer. American College of Obstetricians and Gynecologists. Available at: https:\/\/www.acog.org\/clinical\/clinical-guidance\/clinical-consensus\/articles\/2021\/12\/treatment-of-urogenital-symptoms-in-individuals-with-a-history-of-estrogen-dependent-breast-cancer. Accessed July 9, 2024."},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0084","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0085","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0086","doi-asserted-by":"crossref","first-page":"e12763","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: Considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0087","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1076029616683802","article-title":"Oral contraceptives and HRT risk of thrombosis","volume":"24","author":"Gialeraki","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0088","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy\u2013results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)","volume":"84","author":"H\u00f8ibraaten","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0089","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2024.10.023_bib0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2017.03.013","article-title":"Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey","volume":"153","author":"Klok","year":"2017","journal-title":"Thromb Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:19Z","timestamp":1740134839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624035119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0360301624035119"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.023","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}